Outcomes of Patients Who Undergo Cardiac Surgical Procedures After Liver Transplantation Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S. Bryant, MSPH, MD, Payden Wallace, BS, Julia Massey, BS, Stephen Gray, MD, Manish Kukreja, MBBS, MPH, David C. Cleveland, MBA, MD, James K. Kirklin, MD, James E. Davies, MD The Annals of Thoracic Surgery Volume 103, Issue 2, Pages 541-545 (February 2017) DOI: 10.1016/j.athoracsur.2016.06.023 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier survival stratified by preoperative Model for End-Stage Liver Disease (MELD) score (log-rank; p = 0.028). The Annals of Thoracic Surgery 2017 103, 541-545DOI: (10.1016/j.athoracsur.2016.06.023) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Kaplan-Meier survival stratified by postoperative Model for End-Stage Liver Disease (MELD) score (log-rank; p < 0.001). The Annals of Thoracic Surgery 2017 103, 541-545DOI: (10.1016/j.athoracsur.2016.06.023) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier overall survival curve. The Annals of Thoracic Surgery 2017 103, 541-545DOI: (10.1016/j.athoracsur.2016.06.023) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Hazard survival after cardiac surgical procedures in patients who had a liver transplant at the University of Alabama at Birmingham School of Medicine, Birmingham, Alabama between 1991 and 2012 (N = 43). The Annals of Thoracic Surgery 2017 103, 541-545DOI: (10.1016/j.athoracsur.2016.06.023) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions